Deniz Bagdas Selected Research

4- (4- bromophenyl)- 3a,4,5,9b- tetrahydro- 3H- cyclopenta(c)quinoline- 8- sulfonamide

1/2018	Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states.
1/2016	The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deniz Bagdas Research Topics

Disease

17	Pain (Aches) 12/2021 - 09/2011
14	Neuralgia (Stump Neuralgia) 12/2021 - 09/2011
11	Hyperalgesia 12/2021 - 09/2011
8	Inflammation (Inflammations) 01/2020 - 10/2013
7	Chronic Pain 12/2021 - 04/2015
6	Tobacco Use Disorder (Nicotine Dependence) 01/2022 - 10/2014
6	Hypersensitivity (Allergy) 01/2021 - 01/2019
5	Neoplasms (Cancer) 01/2021 - 01/2017
5	Peripheral Nervous System Diseases (PNS Diseases) 01/2021 - 10/2015
4	Edema (Dropsy) 01/2021 - 10/2015
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2019 - 01/2018
2	Mood Disorders (Mood Disorder) 01/2022 - 01/2017
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 10/2018
2	Binge Drinking 10/2019 - 01/2019
2	Alcoholism (Alcohol Abuse) 01/2019 - 01/2018
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 10/2018 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2017
2	Anhedonia 10/2017 - 01/2017
2	Wounds and Injuries (Trauma) 07/2015 - 11/2014
1	Carcinogenesis 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Adenocarcinoma 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Body Weight Changes 01/2020
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Peripheral Nerve Injuries 01/2019
1	Lewis Lung Carcinoma 01/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2018
1	Hypothermia 01/2018
1	Visceral Pain 01/2018
1	Necrosis 06/2017

Drug/Important Bio-Agent (IBA)

15	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 12/2021 - 06/2007
14	Nicotine FDA Link 01/2020 - 10/2014
8	Pharmaceutical PreparationsIBA 01/2021 - 04/2015
7	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2017
6	Analgesics (Analgesic Drugs)IBA 12/2021 - 10/2013
6	Freund's AdjuvantIBA 01/2020 - 10/2015
5	Formaldehyde (Formol)FDA Link 12/2021 - 04/2015
4	Chlorogenic AcidIBA 01/2020 - 10/2013
3	LigandsIBA 12/2021 - 04/2017
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021 - 01/2017
3	Morphine (MS Contin)FDA LinkGeneric 01/2020 - 03/2016
3	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 12/2019 - 10/2014
3	Ethanol (Ethyl Alcohol)IBA 12/2019 - 01/2018
3	Acetic Acid (Vinegar)FDA LinkGeneric 01/2019 - 04/2015
3	Cholinergic ReceptorsIBA 01/2018 - 09/2011
3	CarrageenanIBA 11/2015 - 09/2011
3	Cytidine Diphosphate Choline (Citicoline)IBA 12/2013 - 06/2007
2	Menthol FDA Link 01/2022 - 01/2020
2	AntioxidantsIBA 01/2020 - 07/2015
2	SolutionsIBA 01/2020 - 04/2017
2	Opioid Receptors (Opioid Receptor)IBA 12/2019 - 09/2011
2	4- (4- bromophenyl)- 3a,4,5,9b- tetrahydro- 3H- cyclopenta(c)quinoline- 8- sulfonamideIBA 01/2018 - 01/2016
2	Varenicline (Chantix)FDA Link 01/2018 - 01/2018
2	1,4- diazabicyclo(3.2.2)nonan- 4- yl(5- (3- (trifluoromethyl)phenyl)furan- 2- yl)methanoneIBA 01/2018 - 04/2015
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2017 - 07/2015
2	Choline (Choline Chloride)IBA 04/2017 - 09/2011
2	Superoxide DismutaseIBA 07/2015 - 11/2014
2	CatalaseIBA 07/2015 - 11/2014
2	Glutathione (Reduced Glutathione)IBA 07/2015 - 11/2014
2	Streptozocin (Streptozotocin)FDA Link 07/2015 - 06/2014
1	Cholinergic Agents (Cholinergics)IBA 01/2022
1	Flavoring AgentsIBA 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	FructoseIBA 01/2021
1	palmidrolIBA 01/2021
1	Plant NectarIBA 01/2021
1	N-acylethanolaminesIBA 01/2021
1	benz(a)anthracene (benzanthracene)IBA 01/2021
1	SugarsIBA 01/2021
1	CytokinesIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 10/2019
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2019
1	Sirtuin 2IBA 01/2019
1	Neurotransmitter Agents (Neurotransmitter)IBA 10/2018
1	MJN110IBA 01/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2018
1	JZL 184IBA 01/2018
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2018
1	methyllycaconitineIBA 01/2018
1	desformylflustrabromineIBA 01/2018
1	MecamylamineIBA 01/2018
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018
1	Monoacylglycerol LipasesIBA 01/2018
1	CurcuminIBA 01/2018
1	EnzymesIBA 01/2018
1	taxaneIBA 01/2018
1	CannabinoidsIBA 01/2018
1	SmokeIBA 01/2018
1	Glucagon-Like Peptides (Enteroglucagon)IBA 06/2017
1	AdrenomedullinIBA 06/2017
1	CotinineIBA 06/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 06/2017
1	nornicotineIBA 06/2017

Therapy/Procedure

4	Therapeutics 10/2019 - 07/2015
3	Drug Therapy (Chemotherapy) 10/2019 - 01/2017
1	Injections 01/2021
1	Analgesia 12/2019
1	Aftercare (After-Treatment) 01/2018
1	Hypnosis (Mesmerism) 01/2018